3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
15
NETWORK
1
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Neoplasms
9
Carcinoma, Non-Small-Cell Lung
7
Colorectal Neoplasms
6
Breast Neoplasms
6
Prostatic Neoplasms
5
Papillomavirus Infections
5
Ovarian Neoplasms
4
Neoplastic Cells, Circulating
4
Uterine Cervical Neoplasms
3
Uterine Cervical Dysplasia
3
Lung Neoplasms
3
Melanoma
2
Lymphoma, Follicular
2
Leukemia, Myeloid, Acute
2
Hematologic Neoplasms
2
Carcinoma, Hepatocellular
2
Thymic aplasia
1
Stomach Neoplasms
1
Solid Tumor, Adult
1
Small Cell Lung Carcinoma
1
Respiratory Distress Syndrome
1
Recurrence
1
Rectal Neoplasms
1
Radiation Injuries
1
Pulmonary Disease, Chronic Obstructive
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Opioid-Related Disorders
1
Interventions
pembrolizumab
98
Gemcitabine
70
Paclitaxel
59
Docetaxel
52
Carboplatin
49
Cisplatin
40
Nivolumab
39
Capecitabine
35
Pemetrexed
33
Fluorouracil
32
Bevacizumab
32
Cetuximab
31
130-nm albumin-bound paclitaxel
28
Trastuzumab
26
Irinotecan
24
Albumin-Bound Paclitaxel
24
Fulvestrant
22
Leucovorin
20
Oxaliplatin
18
Panitumumab
17
abemaciclib
16
Ipilimumab
16
Cyclophosphamide
15
cemiplimab
14
atezolizumab
14
Letrozole
14
palbociclib
12
Lapatinib
12
Drug Therapy
12
Doxorubicin
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Neoplasm Metastasis
×
Blood Specimen Collection
×
Clear all
NCT03427450
2023-06-05
HOMING
Angle plc
Completed
421 enrolled